Brief: Fine Foods & Pharmaceuticals H1 EBITDA Adj. €15.2 Mln, EBITDA Margin Adj. At 12.2%
08/09/2026 13:09
BRIEF-Fine Foods & Pharmaceuticals H1 EBITDA Adj. €15.2 Mln, EBITDA Margin Adj. At 12.2% Sept 8 (Reuters) - Fine Foods & Pharmaceuticals NTM SpA FF.MI:
H1 2026 CONSOLIDATED REVENUE AT €124.8 MILLION
H1 2026 EBITDA ADJUSTED €15.2 MILLION, EBITDA MARGIN ADJUSTED 12.2%
H1 2026 NET RESULT ADJUSTED €2.1 MILLION
Further company coverage: FF.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Fine Foods & Pharmaceuticals NTM SpA
See all newsBrief: Fine Foods & Pharmaceuticals H1 EBITDA Adj. €15.2 Mln, EBITDA Margin Adj. At 12.2%
Brief: Fine Foods Completes Acquisition Of 100% Of Sofar For EUR 23.4 Mln
Brief: Fine Foods Q1 Net Profit EUR 0.8 Mln
Brief: Fine Foods & Pharmaceuticals Ntm To Buy 100% Of Sofar From Alfasigma
Brief: Fine Foods FY Net Profit EUR 10.1 Mln